132 related articles for article (PubMed ID: 9161879)
1. Characterization of a series of vacuolar type H(+)-ATPase inhibitors on CTL-mediated cytotoxicity.
Togashi K; Kataoka T; Nagai K
Immunol Lett; 1997 Mar; 55(3):139-44. PubMed ID: 9161879
[TBL] [Abstract][Full Text] [Related]
2. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
3. Inactivation and proteolytic degradation of perforin within lytic granules upon neutralization of acidic pH.
Kataoka T; Togashi K; Takayama H; Takaku K; Nagai K
Immunology; 1997 Jul; 91(3):493-500. PubMed ID: 9301542
[TBL] [Abstract][Full Text] [Related]
4. Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity.
Kataoka T; Takaku K; Magae J; Shinohara N; Takayama H; Kondo S; Nagai K
J Immunol; 1994 Nov; 153(9):3938-47. PubMed ID: 7930604
[TBL] [Abstract][Full Text] [Related]
5. FD-891, a structural analogue of concanamycin A that does not affect vacuolar acidification or perforin activity, yet potently prevents cytotoxic T lymphocyte-mediated cytotoxicity through the blockage of conjugate formation.
Kataoka T; Yamada A; Bando M; Honma T; Mizoue K; Nagai K
Immunology; 2000 Jun; 100(2):170-7. PubMed ID: 10886392
[TBL] [Abstract][Full Text] [Related]
6. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T
J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142
[TBL] [Abstract][Full Text] [Related]
7. Prodigiosin 25-C suppression of cytotoxic T cells in vitro and in vivo similar to that of concanamycin B, a specific inhibitor of vacuolar type H(+)-ATPase.
Lee MH; Kataoka T; Magae J; Nagai K
Biosci Biotechnol Biochem; 1995 Aug; 59(8):1417-21. PubMed ID: 7549091
[TBL] [Abstract][Full Text] [Related]
8. Estimation of pH and the number of lytic granules in a CD8+ CTL clone treated with an inhibitor of vacuolar type H(+)-ATPase concanamycin A.
Kataoka T; Sato M; Kondo S; Nagai K
Biosci Biotechnol Biochem; 1996 Oct; 60(10):1729-31. PubMed ID: 8987677
[TBL] [Abstract][Full Text] [Related]
9. Identification of low molecular weight probes on perforin- and Fas-based killing mediated by cytotoxic T lymphocytes.
Kataoka T; Taniguchi M; Yamada A; Suzuki H; Hamada S; Magae J; Nagai K
Biosci Biotechnol Biochem; 1996 Oct; 60(10):1726-8. PubMed ID: 8987676
[TBL] [Abstract][Full Text] [Related]
10. In vivo rapid reduction of alloantigen-activated CD8+ mature cytotoxic T cells by inhibitors of acidification of intracellular organelles, prodigiosin 25-C and concanamycin B.
Lee MH; Kataoka T; Honjo N; Magae J; Nagai K
Immunology; 2000 Feb; 99(2):243-8. PubMed ID: 10692043
[TBL] [Abstract][Full Text] [Related]
11. Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity.
Kojima Y; Kawasaki-Koyanagi A; Sueyoshi N; Kanai A; Yagita H; Okumura K
Biochem Biophys Res Commun; 2002 Aug; 296(2):328-36. PubMed ID: 12163021
[TBL] [Abstract][Full Text] [Related]
12. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway.
Isaaz S; Baetz K; Olsen K; Podack E; Griffiths GM
Eur J Immunol; 1995 Apr; 25(4):1071-9. PubMed ID: 7737276
[TBL] [Abstract][Full Text] [Related]
13. Interaction of chondroitin sulfate with perforin and granzymes of cytolytic T-cells is dependent on pH.
Masson D; Peters PJ; Geuze HJ; Borst J; Tschopp J
Biochemistry; 1990 Dec; 29(51):11229-35. PubMed ID: 2125503
[TBL] [Abstract][Full Text] [Related]
14. Destruxin B, a specific and readily reversible inhibitor of vacuolar-type H(+)-translocating ATPase.
Muroi M; Shiragami N; Takatsuki A
Biochem Biophys Res Commun; 1994 Dec; 205(2):1358-65. PubMed ID: 7802670
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.
Berke G; Rosen D; Ronen D
Immunology; 1993 Jan; 78(1):105-12. PubMed ID: 8436395
[TBL] [Abstract][Full Text] [Related]
16. Induction of EGF-dependent apoptosis by vacuolar-type H(+)-ATPase inhibitors in A431 cells overexpressing the EGF receptor.
Yoshimoto Y; Imoto M
Exp Cell Res; 2002 Sep; 279(1):118-27. PubMed ID: 12213220
[TBL] [Abstract][Full Text] [Related]
17. Perforin granule release from cytotoxic lymphocytes ex vivo is inhibited by ciclosporin but not by methotrexate.
Ambach A; Bonnekoh B; Gollnick H
Skin Pharmacol Appl Skin Physiol; 2001; 14(5):249-60. PubMed ID: 11586066
[TBL] [Abstract][Full Text] [Related]
18. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
[TBL] [Abstract][Full Text] [Related]
19. Myeloma-reactive allospecific cytotoxic T lymphocytes lyse target cells via the granule exocytosis pathway.
Chiriva-Internati M; Du J; Cannon M; Barlogie B; Yi Q
Br J Haematol; 2001 Feb; 112(2):410-20. PubMed ID: 11167840
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
Makrigiannis AP; Hoskin DW
J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
